LONDON (Reuters) - Giving cheap aspirin to cancer patients may turbo-charge the effectiveness of expensive new medicines that help their immune systems fight tumors, experiments on mice suggest.

There are multiple risk factors for the development of cardiovascular disease, including high blood pressure, elevated cholesterol, diabetes mellitus, tobacco use, family history and central obesity.

Aspirin: A New Tool to Fight Coronavirus? “This is a critical finding that needs to be confirmed through a randomized clinical trial,” the study’s lead author Dr. Jonathan Chow said in a news release.